Animal Models for the Development of New Neuropharmacological Therapeutics in the Status Epilepticus

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|4|1|33-40

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.4, Iss.1, 2006-01, pp. : 33-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Shigella Vaccine Development: Prospective Animal Models and Current Status

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 10, 2013-11 ,pp. : 903-912

Bentham Science Publishers

Access to resources Recommend Favorite

Nonhuman primates as models for the discovery and development of ebolavirus therapeutics

By Shurtleff Amy C   Warren Travis K   Bavari Sina  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 3, 2011-03 ,pp. : 233-250

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Status Epilepticus in Children

By De Negri M.   Baglietto M.G.  

Pediatric Drugs, Vol. 3, Iss. 6, 2001-01 ,pp. : 411-420

Adis International

Access to resources Recommend Favorite

Status Epilepticus: An Overview

By  

Current Drug Metabolism, Vol. 18, Iss. 3, 2017-03 ,pp. : 174-185

Bentham Science Publishers

Access to resources Recommend Favorite

Cerebral distribution of polyamines in kainic acid-induced models of status epilepticus and ataxia in rats. Overproduction of putrescine and histological damage

By de Vera N.   Camon L.   Martnez E.  

European Neuropsychopharmacology, Vol. 12, Iss. 5, 2002-10 ,pp. : 397-405

Elsevier

Access to resources Recommend Favorite